Improving Bioprocess Conditions for the Production of Prodigiosin Using a Marine Serratia rubidaea Strain
Marine Drugs · 2024
DOI: 10.3390/md22040142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Ricardo F S Pereira und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, iBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais,…. Hauptthemen laut MEDLINE: Prodigiosin, Bioreactors, Serratia, Culture Media. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Fundação para a Ciência e Tecnologia, European Union’s Horizon 2020 Research and Innovation Programme.
Abstract (Originalsprache)
The enormous potential attributed to prodigiosin regarding its applicability as a natural pigment and pharmaceutical agent justifies the development of sound bioprocesses for its production. Using a Serratia rubidaea strain isolated from a shallow-water hydrothermal vent, optimization of the growth medium composition was carried out. After medium development, the bacterium temperature, light and oxygen needs were studied, as was growth inhibition by product concentration. The implemented changes led to a 13-fold increase in prodigiosin production in a shake flask, reaching 19.7 mg/L. The conditions allowing the highest bacterial cell growth and prodigiosin production were also tested with another marine strain: S. marcescens isolated from a tide rock pool was able to produce 15.8 mg/L of prodigiosin. The bioprocess with S. rubidaea was scaled up from 0.1 L shake flasks to 2 L bioreactors using the maintenance of the oxygen mass transfer coefficient (kLa) as the scale-up criterion. The implemented parameters in the bioreactor led to an 8-fold increase in product per biomass yield and to a final concentration of 293.1 mg/L of prodigiosin in 24 h.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, iBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
- Associate Laboratory i4HB-Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
ORCID-Profile: Ricardo F S Pereira, Carla C C R de Carvalho
Förderung
- European Commission
- Fundação para a Ciência e Tecnologia
- European Union’s Horizon 2020 Research and Innovation Programme
- Fundação para a Ciência e a Tecnologia (FCT, Portugal)
- Research Unit iBB—Institute for Bioengineering and Biosciences
- i4HB—Associate Laboratory Institute for Health and Bioeconomy
Zitieren
APA
Pereira, R. F. S., & de Carvalho, C. C. C. R. (2024). Improving Bioprocess Conditions for the Production of Prodigiosin Using a Marine Serratia rubidaea Strain. Marine Drugs. https://doi.org/10.3390/md22040142
Vancouver
Pereira RFS, de Carvalho CCCR. Improving Bioprocess Conditions for the Production of Prodigiosin Using a Marine Serratia rubidaea Strain. Marine Drugs. 2024. doi:10.3390/md22040142
BibTeX
@article{Pereira2024,
author = {Pereira, Ricardo F S and de Carvalho, Carla C C R},
title = {Improving Bioprocess Conditions for the Production of Prodigiosin Using a Marine Serratia rubidaea Strain},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22040142}
}
EUVIMED